AUBERTON-HERVE ANDRE-JACQUES 4
4 · Bionik Laboratories Corp. · Filed Apr 9, 2019
Insider Transaction Report
Form 4
AUBERTON-HERVE ANDRE-JACQUES
Director
Transactions
- Conversion
Common Stock
2019-03-28$3.89/sh+81,492$316,800→ 224,475 total(indirect: Shares held through Star SCI and 4A Consulting & Engineering)
Footnotes (2)
- [F1]Effective as of March 28, 2019, an aggregate amount of $316,800 of principal and accrued interest in convertible promissory notes issued to Star SCI (the "Notes") converted in accordance with their terms into 81,492 shares of the Issuer's common stock.
- [F2]The conversion price of the Notes was calculated using the VWAP (as defined in the Notes) average of the last 30 days before March 28, 2019.